Charles F Seifert

Suggest Changes
Learn More
OBJECTIVES To evaluate whether the direct renin inhibitor, aliskiren, has a more favorable effect compared to amlodipine on atherosclerotic biomarkers in patients with stable coronary artery disease(More)